Interpretation of guideline for the prevention and management of perioperative venous thromboembolism in thoracic malignancies in China (2022 version)_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 LI Hui

Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, P. R. China;

Corresponding author：

LI Hui, Email: huilee@vip.sina.com

Keywords：

Thoracic malignancy; venous thromboembolism; perioperative period; prevention; interpretation

DOI：

10.7507/1007-4848.202207056

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Patients with thoracic malignancy have a high incidence of perioperative venous thromboembolism (VTE), but its onset is insidious, often asymptomatic or atypical, and is easily overlooked. Early identification and standardized prevention of VTE can effectively reduce the risk of VTE. "Guideline for the prevention and management of perioperative venous thromboembolism in thoracic malignancies in China (2022 version)" has been officially released recently. This article closely follows the context, significance, core implications, and the impact of future VTE prevention in thoracic surgery. It is hoped that through our joint efforts, we can reduce the incidence of perioperative VTE and mortality of thoracic surgery, and strive to improve the long-term survival of patients with lung cancer and esophageal cancer.

Citation： LI Hui. Interpretation of guideline for the prevention and management of perioperative venous thromboembolism in thoracic malignancies in China (2022 version). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(10): 1239-1242. doi: 10.7507/1007-4848.202207056 Copy

1.	李辉, 姜格宁. 胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版). 中国肺癌杂志, 2018, 21(10): 739-752.
2.	中国胸部恶性肿瘤围手术期静脉血栓栓塞症研究组. 中国胸部恶性肿瘤围手术期静脉血栓栓塞症预防与管理指南(2022 版). 中华外科杂志, 2022, 60(8): 721-731.
3.	Zhang S, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2015. JNCC, 2021, 1(1): 2-11.
4.	Khorana AA. The NCCN clinical practice guidelines on venous thromboembolic disease: Strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist, 2007, 12(11): 1361-1370.
5.	Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer, 2012, 78(2): 161-166.
6.	Mukherjee D, Lidor AO, Chu KM, et al. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg, 2008, 12(11): 2015-2022.
7.	Hewes PD, Hachey KJ, Zhang XW, et al. Evaluation of the Caprini model for venothromboembolism in esophagectomy patients. Ann Thorac Surg, 2015, 100(6): 2072-2078.
8.	宋春凤, 李辉, 田博, 等. 中国胸外科术后静脉血栓栓塞症现状的问卷调查分析. 中华外科杂志, 2017, 55, (9): 661-666.
9.	Song C, Shargall Y, Li H, et al. Prevalence of venous thromboembolism after lung surgery in China: A single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis. Eur J Cardiothorac Surg, 2019, 55(3): 455-460.
10.	邓宇, 高明朗, 曾国军, 等. 美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读. 中国胸心血管外科临床杂志, 2022, 29(3): 275-278.
11.	Trinh VQ, Karakiewicz PI, Sammon J, et al. Venous thromboembolism after major cancer surgery: Temporal trends and patterns of care. JAMA Surg, 2014, 149(1): 43-49.
12.	Zhai Z, Kan Q, Li W, et al. VTE risk profiles and prophylaxis in medical and surgical inpatients: The identification of chinese hospitalized patients' risk profile for venous thromboembolism (dissolve-2): A cross-sectional study. Chest, 2019, 155(1): 114-122.

1. 李辉, 姜格宁. 胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版). 中国肺癌杂志, 2018, 21(10): 739-752.
2. 中国胸部恶性肿瘤围手术期静脉血栓栓塞症研究组. 中国胸部恶性肿瘤围手术期静脉血栓栓塞症预防与管理指南(2022 版). 中华外科杂志, 2022, 60(8): 721-731.
3. Zhang S, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2015. JNCC, 2021, 1(1): 2-11.
4. Khorana AA. The NCCN clinical practice guidelines on venous thromboembolic disease: Strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist, 2007, 12(11): 1361-1370.
5. Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer, 2012, 78(2): 161-166.
6. Mukherjee D, Lidor AO, Chu KM, et al. Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg, 2008, 12(11): 2015-2022.
7. Hewes PD, Hachey KJ, Zhang XW, et al. Evaluation of the Caprini model for venothromboembolism in esophagectomy patients. Ann Thorac Surg, 2015, 100(6): 2072-2078.
8. 宋春凤, 李辉, 田博, 等. 中国胸外科术后静脉血栓栓塞症现状的问卷调查分析. 中华外科杂志, 2017, 55, (9): 661-666.
9. Song C, Shargall Y, Li H, et al. Prevalence of venous thromboembolism after lung surgery in China: A single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis. Eur J Cardiothorac Surg, 2019, 55(3): 455-460.
10. 邓宇, 高明朗, 曾国军, 等. 美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读. 中国胸心血管外科临床杂志, 2022, 29(3): 275-278.
11. Trinh VQ, Karakiewicz PI, Sammon J, et al. Venous thromboembolism after major cancer surgery: Temporal trends and patterns of care. JAMA Surg, 2014, 149(1): 43-49.
12. Zhai Z, Kan Q, Li W, et al. VTE risk profiles and prophylaxis in medical and surgical inpatients: The identification of chinese hospitalized patients' risk profile for venous thromboembolism (dissolve-2): A cross-sectional study. Chest, 2019, 155(1): 114-122.

Next Article
Current situation and prospect of interventional therapy for congenital heart disease in China

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Interpretation of guideline for the prevention and management of perioperative venous thromboembolism in thoracic malignancies in China (2022 version)

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content